Why Novavax (NVAX) Stock Price Appreciated 14% on Monday

In addition to the above deal, Sanofi also agreed to make an equity investment of nearly $70 million in Novavax in exchange for a 4.9% stake. Shah Capital launched its proxy fight days before the deal with Sanofi was announced, urging investors to vote against three incumbent directors and opposed proposals related to executive compensation at the company's annual meeting on Jun 13. Despite the campaign withdrawal, Shah will continue to monitor the company as it believes that 'significant additional value r ...